Engineered PLGA microspheres for extended-release of naltrexone:
IVIVR
Naltrexone
PLGA
drug delivery
microsphere
opioid
Journal
Pharmaceutical development and technology
ISSN: 1097-9867
Titre abrégé: Pharm Dev Technol
Pays: England
ID NLM: 9610932
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
pubmed:
24
1
2023
medline:
15
3
2023
entrez:
23
1
2023
Statut:
ppublish
Résumé
Poly(lactide-co-glycolide) (PLGA)-based formulation is one of the most often used parenteral extended-release forms to deliver various therapeutics. VIVITROL
Identifiants
pubmed: 36688610
doi: 10.1080/10837450.2023.2172041
doi:
Substances chimiques
Lactic Acid
33X04XA5AT
Naltrexone
5S6W795CQM
Polyglycolic Acid
26009-03-0
Polylactic Acid-Polyglycolic Acid Copolymer
1SIA8062RS
Polyglactin 910
34346-01-5
Drug Carriers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM